Company profilePharmaceutical#447 of 1,318 in Pakistan✓ No DRAP alerts

PHARMA HEALTH

Pharmaceutical company · 35 brands · 28 molecules

Ranked #3 of 58 companies in Skin Conditions

35 registered products 30 pharmaceutical brands 28 distinct molecules 0 DRAP alerts

Company overview

35
registered products
30
pharmaceutical brands
28
distinct molecules
12
therapeutic classes
0
DRAP alerts

PHARMA HEALTH is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 35 product registrations across 28 distinct molecules. Its portfolio is concentrated in Skin Conditions and Corticosteroid Combinations, Topical. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by PHARMA

25 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Other Dermatological Preparations 1
Antifungal For Dermatological 1
Anti-Infectives 1

Top molecules by brand count

Therapeutic classes

Skin Conditions · 19Corticosteroid Combinations, Topical · 5Anti-Acne Preparations · 4Anti-Infectives · 3Unmapped-Medicine · 3Antifungal For Dermatological · 2Corticosteroid, Plain · 2Stomatologicals Preparations · 1Other Beta-Lactam, Cephalosporins & Penems · 1Antipsoriatics · 1Ectoparasiticides; Scabicides · 1Hormone Regulators · 1

Conditions treated

Eczema/Psoriasis/Dermatitis · 9Fungal Infection · 3Acne/Topical · 2Infection/Allergy · 2Hyperpigmentation · 2Scabies · 2Warts · 1Acne/Oral · 1Hormonal Therapy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 123.9 – Rs 922.27
DVAGO23 products · Rs 142.51 – Rs 4,295
Servaid29 products · Rs 71 – Rs 2,800
Median across source: Rs 221

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

VALOR PHARMACEUTICALS20 shared molecules
BIO LABS (PVT) LTD.18 shared molecules
PEARL PHARMACEUTICALS15 shared molecules
DERMA TECHNO PAKISTAN15 shared molecules
SHROOQ PHARMACEUTICALS14 shared molecules
CRYSTOLITE PHARMACEUTICALS13 shared molecules
TABROS PHARMA (PVT). LTD.12 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

VALOR PHARMACEUTICALS holds 151 molecules not in this portfolio
000 I.UAcetylcysteineAcitretinAcyclovirAdapaleneAdaplene
BIO LABS (PVT) LTD. holds 134 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
Atco Pharma International (Pvt) Ltd holds 222 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline

Get the full profile for PHARMA

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.